Boston Scientific News

NEW YORK &#8212 Shares of some top medical devices companies are down at 10 a.m.: Allergan fell $1.06 or 1.2 percent, to $89.19. Baxter International Inc.

The longevity projections are based on data submitted to the FDA and vary for each device dependent on the model type and settings.

The FDA has cleared a device made by Boston Scientific Corp. of Natick for an alternative to existing methods to remove large common bile duct stones.

Belo Sun Mining Corp. is pleased to announce that it has acquired the material surface rights at its 100% owned Volta Grande gold project in Para State, Brazil.

Ashish is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited.

"To get lifesaving drugs and devices to the patients that need them as quickly as possible, Congress must give the Food and Drug Administration the tools it needs to review and approve these products," Senate Majority Leader Harry Reid stated on the Senate floor.

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy.

CINCINNATI, May 24, 2012 - Omnicare, Inc. , today announced the appointment of Sam R. Leno to its Board of Directors and he will also become a member of the Audit Committee.

The diagnostics imaging company also drafted Sam Leno in as chairman of the audit committee, and member of the board.

Med-tech isn't much different than any other sector of the market; when the growth goes, so do the investors.

Medtronic Inc. is scheduled to release earnings on May 22, 2012, and ahead of that announcement, the company is looking strong.

Shares of Boston Scientific Corporation ended the trading session lower by $0.12 or -1.89% from its previous close.

Boston Scientific Corporation announces two-year results from the PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness outcomes for the 2.25 mm PROMUS Elementa Everolimus-Eluting Platinum Chromium Stent System in treating de novo coronary lesions in small coronary vessels.  Analysis of the data was presented today at ... (more)

On Friday, the Boston Business Journal Research Department published the BBJ 150, a list of the top 150 public companies in Massachusetts, ranked by 2011 revenue.

NATICK, Mass., May 18, 2012 /PRNewswire/ -- Boston Scientific Corporation announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week , May 19 - 22 in San Diego.

Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing.

Boston Scientific Corporation announces U.S. Food and Drug Administration approval and market launch of the Epica Vascular Self-Expanding Stent System.A The Epic Stent is designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow.

Boston Scientific +4.1% AH after the FDA approves its Epic vascular stent designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow.

NEW YORK &#8212 Shares of some top medical devices companies are mixed at 1 p.m.: Allergan fell $1.38 or 1.5 percent, to $89.95. Baxter International Inc.

Follow-up Data from EVOLVE Trial Presented at EuroPCR; Trial is Evaluating Next-Generation Everolimus-Eluting Platinum Chromium Coronary Stent with Ultra-Thin Bioabsorbable Abluminal Polymer /PRNewswire/ -- Boston Scientific Corporation announces that the SYNERGYTM Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium Coronary Stent ... (more)